OTCMKTS:ONPH

Oncology Pharma - ONPH Stock Forecast, Price & News

$0.48

0.00 (0.00%)

(As of 10/4/2022 12:00 AM ET)

Add

Compare

Today's Range: $0.48
▼
$0.64
50-Day Range: $0.44
▼
$1.41
52-Week Range: $0.40
▼
$17.70

Volume: 39,811 shs
Average Volume: 90,447 shs
Market Capitalization: $18.26 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Oncology Pharma (OTCMKTS:ONPH) Stock

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.

Receive ONPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncology Pharma and its competitors with MarketBeat's FREE daily newsletter.

ONPH Stock News Headlines

September 29, 2022 | benzinga.com

PharmaForce International: Leading Oncology Companies in Europe Move to Digital Promotional Methods

September 29, 2022 | msn.com

Why the ‘Cancer Moonshot' Will Never Leave the Launchpad

September 28, 2022 | benzinga.com

Precision Cancer Consortium Adds New Members in Efforts to Improve Access to Comprehensive Genomic Testing for Patients with Cancer

September 28, 2022 | marketwatch.com

Aura Biosciences Doses First Patient in Cancer Drug Belzupacap Sarotalocan Study, Shares Rise

September 27, 2022 | technews.tmcnet.com

Foghorn Therapeutics to Participate in the Bank of America 2022 Precision Oncology Conference

September 17, 2022 | seekingalpha.com

Only 75% of accelerated non-cancer drug approvals led to full approvals - study

September 12, 2022 | apnews.com

US Biliary Cancer Market and Competitive Landscape 2022 - ResearchAndMarkets.com

September 12, 2022 | msn.com

The aftermath of childhood cancer: 2,000 days without Ana

September 8, 2022 | bizjournals.com

Why a cutting-edge cancer cell therapy company picked Sacramento for a key manufacturing site

September 6, 2022 | benzinga.com

Cytovia Therapeutics Mourns the Passing of Cancer Immunotherapy Industry Leader and COO Dr. Olivier Jean-Marie Gouédard

August 17, 2022 | apnews.com

EIB to Support Ryvu Therapeutics’ Discovery, Research and Development of New Cancer Treatments with €22 Million

August 11, 2022 | apnews.com

Predictive Oncology Reports Second Quarter 2022 Financial Results

July 12, 2022 | apnews.com

Mission Bio Announces Pharma Assay Development Services for Solid Tumor Research

July 6, 2022 | marketwatch.com

Merck in talks to buy cancer biotech Seagen for about $40 billion

June 4, 2022 | apnews.com

CG Oncology Presents New Clinical Data on Two Ongoing Programs at The American Society of Clinical Oncology (ASCO) 2022 Annual Meeting

May 26, 2022 | apnews.com

Cue Biopharma to Present at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

March 2, 2022 | finance.yahoo.com

Oncology Pharma Reports on Progress with Ribera Solutions

November 30, 2021 | finance.yahoo.com

Oncology Pharma Research and Vision

November 8, 2021 | finance.yahoo.com

Oncology Pharma Reveals Plans for Development of Lead Cancer Drug Candidate

October 29, 2021 | finanznachrichten.de

Oncology Pharma Inc.: Oncology Pharma, Inc. Gives Update on Ongoing Work and Progress

October 27, 2021 | finance.yahoo.com

Oncology Pharma, Inc. Gives Update on Ongoing Work and Progress

August 25, 2021 | finanznachrichten.de

Oncology Pharma Inc.: Oncology Pharma's Co-Development Agreement Pursues Strategic and Direct Objectives

July 31, 2021 | barrons.com

Oncology Pharma Inc.

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ONPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncology Pharma and its competitors with MarketBeat's FREE daily newsletter.

ONPH Company Calendar

Today: 10/04/2022
Fiscal Year End: 3/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Prepackaged software
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:ONPH
CUSIP: N/A
CIK: N/A
Web: www.oncology-pharma.com
Phone: (415) 869-1038
Fax: 858-385-8997
Employees: 1
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 37,963,000
Free Float: 31,130,000
Market Cap: $18.26 million
Optionable: Not Optionable
Beta: -0.57

Key Executives

Mr. Chuck Wagner
Pres, Treasurer & Chairman

Mr. George Malesek
Interim Chief Exec. Officer

Mr. Dimitri Theofilopolous Esq.
Legal Counsel

Key Competitors

View All Competitors

ONPH Stock - Frequently Asked Questions

How have ONPH shares performed in 2022?: Oncology Pharma's stock was trading at $4.05 on January 1st, 2022. Since then, ONPH stock has decreased by 88.1% and is now trading at $0.4810.
View the best growth stocks for 2022 here.
What is Oncology Pharma's stock symbol?: Oncology Pharma trades on the OTCMKTS under the ticker symbol "ONPH."

How do I buy shares of Oncology Pharma?: Shares of ONPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Oncology Pharma's stock price today?: One share of ONPH stock can currently be purchased for approximately $0.48.
How much money does Oncology Pharma make?: Oncology Pharma (OTCMKTS:ONPH) has a market capitalization of $18.26 million.
How can I contact Oncology Pharma?: Oncology Pharma's mailing address is 16855 WEST BERNARDO DRIVE SUITE 260, SAN DIEGO CA, 92127. The official website for the company is www.oncology-pharma.com. The company can be reached via phone at (415) 869-1038 or via fax at 858-385-8997.

This page (OTCMKTS:ONPH) was last updated on 10/5/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms